GTC
EW icon

Ghost Tree Capital’s Edwards Lifesciences EW Stock Holding History

Ghost Tree Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-300,000
Closed -$8.82M – 71
2016
Q1 		$8.82M Buy
+300,000
New +$8.28M 4.99% 4
2014
Q1 		– Sell
-600,000
Closed -$6.58M – 68
2013
Q4 		$6.58M Buy
+600,000
New +$6.76M 4.05% 4

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ghost Tree Capital's EW Position: Q4 2016 in Review

Ghost Tree Capital sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 255,000 shares — an estimated $10.2M sold.

Ghost Tree Capital first reported a position in EW in Q1 2014 and held it in 6 quarters. The position peaked at $10.2M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • Ghost Tree Capital reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
  • Ghost Tree Capital sold 255,000 Edwards Lifesciences shares in Q4 2016, an estimated $10.2M.
  • Ghost Tree Capital first reported a position in Edwards Lifesciences in Q1 2014 and held it in 6 quarters.
  • Ghost Tree Capital's Edwards Lifesciences position peaked at $10.2M in Q3 2016.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Ghost Tree Capital's 13F filing for Q4 2016, filed 14 Feb 2017.